An estimated 7 out of 1,000 pregnant women in the United States experience complications during delivery that put the lives of both mother and baby at risk. But science and technology has found a way to help prepare medical specialists for a host of unforeseen problems. It’s done through a unique mixed reality enhanced learning […]

The biopharmaceutical industry has long struggled with R&D productivity. Long time industry strategic consultant Mike Rea, founder and CEO IDEA Pharma, thinks he’s hit on a possible solution. Taking a cue from the tech industry, Rea in May announced the launch of Protodigm, which he describes as a contract skunkworks company. The approach is intended […]

Cartesian Therapeutics is on a quick pace in a hot space. Founded in 2016, the company has already grown its pipeline of RNA-engineered cell therapies to nine candidates across auto-immune, oncology, and respiratory disease indications. Four of them—Descartes-08 for myasthenia gravis, Descartes-11 and Descartes-08 for myeloma, and Descartes-30 for ARDS—have advanced to phase I/II clinical […]